Orladeyo (berotralstat) — United Healthcare
hereditary angioedema (HAE) prophylaxis
Initial criteria
- Diagnosis of hereditary angioedema (HAE)
- For prophylaxis against HAE attacks
- Not used in combination with other products indicated for prophylaxis against HAE attacks (e.g., Cinryze, Haegarda, Takhzyro)
Approval duration
12 months